• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子受体-1在人结肠癌细胞上的表达及功能

Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells.

作者信息

Fan Fan, Wey Jane S, McCarty Marya F, Belcheva Anna, Liu Wenbiao, Bauer Todd W, Somcio Ray J, Wu Yan, Hooper Andrea, Hicklin Daniel J, Ellis Lee M

机构信息

Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.

出版信息

Oncogene. 2005 Apr 14;24(16):2647-53. doi: 10.1038/sj.onc.1208246.

DOI:10.1038/sj.onc.1208246
PMID:15735759
Abstract

Vascular endothelial growth factor (VEGF) is associated with tumor angiogenesis and poor prognosis in human colorectal cancer (CRC). VEGF receptor-1 (VEGFR-1 or Flt-1) is a high-affinity receptor for VEGF and is typically considered specific to endothelial cells. Here we report the expression and function of VEGFR-1 in CRC cell lines. VEGFR-1 was expressed in all CRC cell lines studied as determined by RT-PCR, Western blot analysis, FACS, and ELISA. Treatment of the human CRC cell lines HT-29 and SW480 with VEGF-A (a ligand for both VEGFR-1 and -2) or VEGF-B (a ligand specific for VEGFR-1) led to activation of Erk-1/2, SAPK/JNK, and translocation of the p65 subunit of nuclear factor-kappaB into the nucleus. Both VEGF-A and -B led to significant induction of cell motility and invasiveness of CRC cells. Stimulation of cells with VEGF-A or -B also led to larger and more numerous colonies in soft agar. However, activation of VEGFR-1 did not increase CRC cell proliferation. In contrast to the previous paradigm that VEGFRs are not present on tumor cells of epithelial origin, we found that VEGFR-1 is present and functional on CRC cells, and activation by VEGF family ligands can activate processes involved in tumor progression and metastasis.

摘要

血管内皮生长因子(VEGF)与人类结直肠癌(CRC)的肿瘤血管生成及不良预后相关。VEGF受体-1(VEGFR-1或Flt-1)是VEGF的高亲和力受体,通常被认为是内皮细胞特有的。在此,我们报告VEGFR-1在结直肠癌细胞系中的表达及功能。通过逆转录聚合酶链反应(RT-PCR)、蛋白质免疫印迹分析、荧光激活细胞分选术(FACS)及酶联免疫吸附测定(ELISA)确定,VEGFR-1在所研究的所有结直肠癌细胞系中均有表达。用VEGF-A(VEGFR-1和-2的配体)或VEGF-B(VEGFR-1特异性配体)处理人结直肠癌细胞系HT-29和SW480,可导致细胞外信号调节激酶-1/2(Erk-1/2)、应激激活蛋白激酶/应激活化蛋白激酶(SAPK/JNK)激活,以及核因子κB(NF-κB)的p65亚基转位至细胞核。VEGF-A和-B均能显著诱导结直肠癌细胞的细胞运动性及侵袭性。用VEGF-A或-B刺激细胞还可导致软琼脂中形成更大且更多的集落。然而,VEGFR-1的激活并未增加结直肠癌细胞的增殖。与之前认为VEGFRs不存在于上皮源性肿瘤细胞上的范例相反,我们发现VEGFR-1存在于结直肠癌细胞上且具有功能,VEGF家族配体的激活可激活参与肿瘤进展和转移的过程。

相似文献

1
Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells.血管内皮生长因子受体-1在人结肠癌细胞上的表达及功能
Oncogene. 2005 Apr 14;24(16):2647-53. doi: 10.1038/sj.onc.1208246.
2
Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.血管内皮生长因子受体-1促进胰腺癌细胞系的迁移和侵袭。
Cancer. 2005 Jul 15;104(2):427-38. doi: 10.1002/cncr.21145.
3
Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage.VEGFR-1(Flt-1)在乳腺癌中的表达与VEGF表达以及无淋巴结转移的肿瘤分期相关。
Anticancer Res. 2008 May-Jun;28(3A):1719-24.
4
Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma.血管内皮生长因子受体-3(VEGFR-3)及其配体VEGF-C在人大肠腺癌中的表达
Anticancer Res. 2002 May-Jun;22(3):1463-6.
5
Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.缺氧诱导癌细胞系中上皮细胞VEGF-C/VEGFR-3上调。
Int J Oncol. 2008 Mar;32(3):585-92.
6
Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.血管内皮生长因子C通过自分泌和旁分泌机制刺激人胃癌进展。
Clin Cancer Res. 2008 Nov 15;14(22):7205-14. doi: 10.1158/1078-0432.CCR-08-0818.
7
Functional VEGF and VEGF receptors are expressed in human medulloblastomas.功能性血管内皮生长因子(VEGF)及其受体在人类髓母细胞瘤中表达。
Neuro Oncol. 2007 Oct;9(4):384-92. doi: 10.1215/15228517-2007-032. Epub 2007 Aug 17.
8
Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中肿瘤细胞上血管内皮生长因子受体的表达
Arch Otolaryngol Head Neck Surg. 2003 Aug;129(8):882-8. doi: 10.1001/archotol.129.8.882.
9
Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.血管内皮生长因子受体-1激活介导人胰腺癌细胞上皮-间质转化。
Cancer Res. 2006 Jan 1;66(1):46-51. doi: 10.1158/0008-5472.CAN-05-3086.
10
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.对植入小鼠肝脏的结肠癌细胞上的神经纤毛蛋白-2进行治疗靶向作用。
J Natl Cancer Inst. 2008 Jan 16;100(2):109-20. doi: 10.1093/jnci/djm279. Epub 2008 Jan 8.

引用本文的文献

1
The VEGFA-Induced MAPK-AKT/PTEN/TGFβ Signal Pathway Enhances Progression and MDR in Gastric Cancer.VEGFA 诱导的 MAPK-AKT/PTEN/TGFβ 信号通路增强胃癌的进展和多药耐药性。
Genes (Basel). 2024 Sep 27;15(10):1266. doi: 10.3390/genes15101266.
2
An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy.一种抗VEGF-B抗体可减少肿瘤异常血管生成并增强化疗效果。
Cancers (Basel). 2024 May 16;16(10):1902. doi: 10.3390/cancers16101902.
3
Meroterpenoids from Marine Sponge sp. and Their Anticancer Activity against Human Colorectal Cancer Cells.
海洋海绵 sp. 的倍半萜类化合物及其对人结肠癌细胞的抗癌活性。
Mar Drugs. 2024 Apr 19;22(4):183. doi: 10.3390/md22040183.
4
The interaction of platelet-related factors with tumor cells promotes tumor metastasis.血小板相关因子与肿瘤细胞的相互作用促进了肿瘤转移。
J Transl Med. 2024 Apr 18;22(1):371. doi: 10.1186/s12967-024-05126-6.
5
evaluation of the antitumor activity of axitinib in canine mammary gland tumor cell lines.阿昔替尼在犬乳腺肿瘤细胞系中的抗肿瘤活性评估。
J Vet Sci. 2024 Jan;25(1):e1. doi: 10.4142/jvs.23191.
6
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids.血管生成素-2与血管内皮生长因子促进肝癌和肝内胆管癌来源的球体迁移和侵袭。
Biomedicines. 2023 Dec 30;12(1):87. doi: 10.3390/biomedicines12010087.
7
Targeting transforming growth factor beta (TGF-β) using Pirfenidone, a potential repurposing therapeutic strategy in colorectal cancer.靶向转化生长因子β(TGF-β)的吡非尼酮,一种结直肠癌潜在的再利用治疗策略。
Sci Rep. 2023 Sep 1;13(1):14357. doi: 10.1038/s41598-023-41550-2.
8
A Novel Gene Signature Associated with Protein Post-translational Modification to Predict Clinical Outcomes and Therapeutic Responses of Colorectal Cancer.一种与蛋白质翻译后修饰相关的新型基因标志物,用于预测结直肠癌的临床结局和治疗反应。
Mol Biotechnol. 2024 Aug;66(8):2106-2122. doi: 10.1007/s12033-023-00852-6. Epub 2023 Aug 17.
9
Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures.新型小分子 LCC-21 通过抑制血管生成和转移特征抑制结直肠癌恶性的临床前评价。
Cells. 2023 Jan 9;12(2):266. doi: 10.3390/cells12020266.
10
Differential presence of exons (DPE): sequencing liquid biopsy by NGS. A new method for clustering colorectal Cancer patients.差异外显子存在(DPE):通过 NGS 对液体活检进行测序。一种用于对结直肠癌患者进行聚类的新方法。
BMC Cancer. 2023 Jan 3;23(1):2. doi: 10.1186/s12885-022-10459-w.